GlobeNewswire

Nexstim Plc: Resolutions of the Extraordinary General Meeting

Share

Company announcement, Helsinki, 1 March 2021 at 2.00 PM (EET)

Nexstim Plc: Resolutions of the Extraordinary General Meeting

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces the resolutions of the Extraordinary General Meeting held today on 1 March 2021 as follows:

1Authorization intended to be used for future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes

The Extraordinary General Meeting resolved unanimously to approve the following authorization in accordance with the proposal of the Board of Directors:

The Extraordinary General Meeting of Shareholders resolved to authorize the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:

The Board of Directors proposes that the Extraordinary General Meeting of Shareholders authorizes the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Companies Act, as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of two hundred twenty million (220,000,000) shares may be issued, which corresponds to approximately 33.35 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

In issue of new ordinary shares, the shareholders have the right to subscribe for new shares in proportion to their existing holdings of the shares of the Company. The Board of Directors has the right to decide upon the offering to parties determined by the Board of Directors of any shares that may remain unsubscribed for pursuant to the shareholders' pre-emptive subscription right. In connection with any shares which remain unsubscribed in such subscription rights issue, the Board of Directors is authorized to resolve on directed share issues or directed issues of option rights or special rights entitling to shares in deviation from the shareholders' pre-emptive right, provided that there is a weighty financial reason for the Company to do so. The shares and option rights or other special rights entitling to shares can hence be issued in one or more tranches. 

In the issuance of shares in the subscription rights issue, the Board of Directors proposes that the preliminary subscription price is EUR 0.03. Taking into account such price level, the major shareholders of the Company, Ossi Haapaniemi, Kyösti Kakkonen and Leena Niemistö each jointly with related-party companies/ book-entry accounts controlled by each, as well as certain members of the Company’s Board of Directors and management team have provided  preliminary commitments to the Company regarding subscription of new shares in such subscription rights issue with certain terms of up to approximately 48% of the authorized amount which would be equal to in aggregate approximately EUR 3,15 million.

The Board of Directors is authorized, at its discretion, to resolve the final subscription price as well as all terms for the share issues and granting of the special rights entitling to shares.

The authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issues and issuances of option rights and other special rights entitling to shares.

The authorization is valid for one (1) year from the decision of the Extraordinary General Meeting of Shareholders.

The authorization may be used for the future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes.

2Authorization intended to be used for the Board’s RSU plan and for the long-term incentive plans for the management and the personnel of the Company

The Extraordinary General Meeting resolved unanimously to approve the following authorization in accordance with the proposal of the Board of Directors:

The Extraordinary General Meeting of Shareholders resolved to authorize the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of nineteen million five hundred thousand (19,500,000) shares may be issued, which corresponds to approximately 4.25 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

The shares, option rights and/or other special rights entitling to shares can be issued in one or more tranches.

The Board of Directors is authorized to resolve on all terms for the share issues and the terms for the granting of the option rights and other special rights entitling to shares. The Board of Directors is authorized to resolve on a directed share issue and issue of the special rights entitling to shares in deviation from the shareholders’ pre-emptive right, provided that there is a weighty financial reason for the Company to do so.

The authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issue, issuing of option rights and other special rights entitling to shares.

The authorization is valid for five (5) years from the decision of the Extraordinary General Meeting of Shareholders.

The authorization may be used to the implementation of the RSU plan for the members of the Board of Director’s and for the long-term incentive plans for the management and the personnel of the Company. The authorization can also be used for incentive arrangements and payment of the Board fees.

3Authorization intended to be used for future financing needs of the Company, developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes

The Extraordinary General Meeting resolved unanimously to approve the following authorization in accordance with the proposal of the Board of Directors:

The Extraordinary General Meeting of Shareholders resolved to authorize the Board of Directors to decide on share issues as well as issues of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:

The shares issued under the authorization are new or those in the Company's possession. Based and within the limits of this authorization, the Board of Directors can also decide on issuance(s) of option rights or other special rights set forth in Chapter 10 the Limited Liability Companies Act complementing or replacing issuance(s) of shares.

Under the authorization, a maximum of five million (5,000,000) shares may be issued, which corresponds to approximately 1.12 percent of all the shares in the Company after the share issue, provided that new shares are issued, considering all registered shares of the Company.

The shares, option rights and/or other special rights entitling to shares can be issued in one or more tranches.

The Board of Directors is authorized to resolve on all terms for the share issues and the terms for the granting of the option rights and other special rights entitling to shares. The Board of Directors is authorized to resolve on a directed share issue and issue of the special rights entitling to shares in deviation from the shareholders’ pre-emptive right, provided that there is a weighty financial reason for the Company to do so. Such new shares may also be issued without payment, provided that there as a particularly weighty financial reason for the Company and considering the interests of its all shareholders to do so.

The authorization does not invalidate prior resolved and registered authorizations made at the General Meeting of Shareholders regarding share issue, issuing of option rights and other special rights entitling to shares.

The authorization is valid for one (1) year from the decision of the Annual General Meeting of Shareholders.

The authorization may be used in connection with future financing needs of the Company (e.g. for a payment of fee payable in Nexstim shares for an investor providing a significant subscription commitment in connection with a possible share issue), developing the equity structure, minimize or reduce debts and possible mergers and acquisitions and other corporate purposes.

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _

The minutes of the Extraordinary General Meeting will be available as from March 15, 2021 at the latest, on the website of the Company www.nexstim.com/investors/shareholder-meetings

NEXSTIM PLC

Leena Niemistö, Chairman of the Board of Directors


Further information is available on the website www.nexstim.com, or by contacting:

Leena Niemistö, Chairman
+358 9 2727 170
leena.niemisto@nexstim.com

Erik Penser Bank AB (Certified Adviser)                        
 +46 8 463 83 00
certifiedadviser@penser.se


About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

RomReal: Mandatory notification of insider trade - Chairman and CEO of RomReal Kjetil Gronskag23.4.2021 17:57:11 CEST | Press release

Kjetil Gronskag, Chairman and CEO of RomReal Ltd has today 23 April 2021, purchased 100 shares of RomReal at NOK 1.85 per share in RomReal Ltd. Following this trade, Kjetil Gronskag controls privately and through holding companies 4,544,127 shares in RomReal Ltd. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

GrandVision's Annual General Meeting (AGM) 2021 adopts all resolutions23.4.2021 16:30:00 CEST | Press release

GrandVision's Annual General Meeting (AGM) 2021 adopts all resolutions Schiphol, the Netherlands - 23 April 2021. GrandVision N.V. (Euronext: GVNV) announced today that its Annual General Meeting (AGM) has approved all resolutions on the agenda of the AGM. The adopted resolutions are listed below: • Adoption of the Annual Accounts for the financial year 2020 as drawn up by the Management Board and signed by the Managing Directors and the Supervisory Directors on 25 February 2021 • Advisory vote on the approval of the remuneration report 2020 • Proposal on dividend distribution for the financial year 2019 of EUR 0.35 per share • Discharge of Managing Directors for their management during the financial year 2020 • Discharge of Supervisory Directors for their supervision of management during the financial year 2020 • Re-appointment of Mr. P. Bolliger as Supervisory Board Director • Re-appointment of Mr. J. Cole as Supervisory Board Director • Appointment of PricewaterhouseCoopers Accounta

CONDITIONS FOR PURCHASES OF CORPORATE BONDS23.4.2021 16:20:00 CEST | Press release

Bid procedure, 2021-04-28BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: VACSE AB: SE0010833012, 2023-09-12 VACSE AB: SE0011062876, 2022-06-07 VASAKRONAN AB: XS1941844174, 2022-02-11 VASAKRONAN AB: XS2048590439, 2022-11-29 NOBINA: SE0012194165, 2024-02-13 VOLVO TREASURY AB: XS2075216395, 2022-11-04 VOLVO TREASURY AB: XS1921474844, 2023-12-13 HOLMEN AB: SE0011426238, 2023-11-24 HOLMEN AB: SE0011281567, 2022-05-23 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2021-03-28Bid date2021-04-28Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SE0010833012: 30 mln SEK +/-30 mln SEK SE0011062876: 30 mln SEK +/-30 mln SEK XS1941844174: 30 mln SEK +/-30 mln SEK XS2048590439: 30 mln SEK +/-30 mln SEK SE0012194165

CONDITIONS FOR RIKSBANK BID PROCEDURE KOMMUNINVEST BONDS23.4.2021 16:20:00 CEST | Press release

Bid procedure, 2021-04-27BondsKOMMUNINVEST I SVERIGE: 2505. SE0011414010. 2025-05-12 KOMMUNINVEST I SVERIGE: 2611, SE0012569572, 2026-11-12 BidsBids on interest and volume are entered via Bloomberg Bond Auction SystemBid date2021-04-27Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)2505: 750 mln SEK +/-350 mln SEK 2611: 500 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)2505: 750 mln SEK per bid 2611: 500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 11.15 (CET/CEST) on the Bid dateDelivery and payment date2021-04-29Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383General Terms and ConditionsGeneral Terms and Conditions General Terms and Conditions för the Riksbank’s Purchases of Bonds via Bid Procedure 2020:3. dated 20 November 2020 (see the Riksbank´s web). S

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS23.4.2021 16:20:00 CEST | Press release

Bid procedure, 2021-04-29BondsSWEDBANK HYPOTEK AB: 192. SE0010133207. 2023-03-15 STADSHYPOTEK AB: 1591, SE0013882644, 2026-06-01 SWEDISH COVERED BOND: 144., SE0011167428, 2023-06-21 SKANDINAVISKA ENSKILDA: 580, SE0013101722, 2025-12-17 LANSFORSAKRINGAR HYPOTEK: 519, SE0012324341, 2026-09-16 DANSKE HYPOTEK AB: 2312, SE0011116474, 2023-12-20 NORDEA HYPOTEK AB: 5535, SE0013358413, 2025-09-17 Bid date2021-04-29Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)192: 800 mln SEK +/-400 mln SEK 1591: 2000 mln SEK +/-1000 mln SEK 144.: 700 mln SEK +/-350 mln SEK 580: 700 mln SEK +/-350 mln SEK 519: 600 mln SEK +/-300 mln SEK 2312: 200 mln SEK +/-100 mln SEK 5535: 1000 mln SEK +/-500 mln SEK Highest permitted bid volume (corresponding nominal amount)192: 800 mln SEK per bid 1591: 2000 mln SEK per bid 144.: 700 mln SEK per bid 580: 700 mln SEK per bid 519: 600 mln SEK per bid 2312: 200 mln SEK per bid 5535: 1000 mln SEK per bid Lowest permitted bid volu

CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER23.4.2021 16:20:00 CEST | Press release

Bid procedure, 2021-04-28CertificateCommercial paper issued in SEK by non-financial companies with their registered office in Sweden and with a remaining maturity of up to six months on the Bid date. i.e. with the latest maturity date as of 2021-10-28 Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 2021-04-16 BidsCounterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to EOL@riksbank.se.Bid date2021-04-28Bid times09.00-09.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 4 billionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 4 billion. No bid may contain Commercial paper in excess of SEK 250 million issued by the s

New Bitwats ASIC Miners Disrupts Crypto Market23.4.2021 14:36:41 CEST | Press release

NEW YORK, April 23, 2021 (GLOBE NEWSWIRE) -- The rapidly evolving global market for cryptocurrency is currently abuzz with the recent introduction of three extraordinarily designed mining rigs, BT, DBT and GBT from BitWats (www.bitwats.com). Instead of focusing only on highly proficient and technology savvy mining stalwarts, these three products were created to allow the casual enthusiasts as well as small-time miners to make their fortune out of crypto mining. DBT offers hash rates of 750 TH/s, 70 GH/s, 5 GH/s, and 5 MH/s, for bitcoin, litecoin, ethereum, and monero respectively. On the other hand, for GBT Miner, the hash power in the same order are 2250 TH/s, 210 GH/s, 15 GH/s, and 15 MH/s. The power consumptions for these two units are 900W and 2200W respectively. Based on figures mentioned above, monthly profit making potential of the two units is as mentioned below. DBT Miner: $7,500 (Bitcoin), $13,000 (Litecoin), $13,000 (Ethereum), and $15,000 (Monero)GBT Miner: $22,500 (Bitcoin